LUminate® Support App
Getting daily support and encouragement can be critical while you are going through opioid withdrawal. The LUminate Support App helps guide you through your LUCEMYRA treatment plan and includes:
- Dose Tracking/Reminders
- Supportive messages each day of treatment
- Symptom Library (including advice and tips for relief)
- Meditation Timer
No need to sign up—simply download the app to start immediately.
Watch the LUminate Support App Video!
LUCEMYRA Educational Brochure
This downloadable brochure provides useful information on how LUCEMYRA can help you get through opioid withdrawal. It shows how and why opioid withdrawal occurs and offers an overview of LUCEMYRA and the LUminate Support Program.
US WorldMeds is not responsible for the content on external websites.
- 24/7, 365-day-a-year helpline (1-800-662-HELP ) providing free and confidential treatment referral and information about mental and/or substance use disorders
- State-by-state access to information about treatment programs
- Find treatment facilities providing a variety of services using the SAMHSA mapping tool
- The National Institute on Drug Abuse (NIDA) is a federal scientific research institute and the world’s largest funder of biomedical research on drug use and addiction. Stay up-to-date on new clinical trials, research, and development
- Nonprofit organization and support for recovering addicts. Provides literature and support, ways to contribute, and locations or weekly recovery meetings
- Provides advocacy, education, support, and public awareness so that all individuals and families affected by mental illness can build better lives
- 24-hour information and support for people suffering with substance use disorder and their families, to better understand addiction, seek help, and find treatment programs and support groups. Hope Line: 1-800-622-2255
- Provides important information about the opioid epidemic, U.S. government efforts to address the crisis, a national helpline, and a treatment locator
- Provides important information for both patients and providers about the opioid epidemic in the U.S.